The CDC and FDA have lifted the suspension on the Johnson & Johnson covid-19 drug.
According to the New York Times, United States health regulators ended the suspension on the single dose shot on Friday after an advisory panel for the Centers for Disease Control and Prevention urged officials to resume its use.
The vaccine was one of three shots that received emergency use authorization from the Food and Drug Administration earlier this year, however its use was halted less than two weeks ago after it was linked to a rare blood clotting disorder.
The U.S. had administered more than 6.8 million doses of the Johnson & Johnson vaccine across the country. Six women who received the injection reportedly suffered blood clotting. Further investigation confirmed nine other women developed blood clots after being vaccinated.
The three of those women have reportedly died from the clots and seven others remain in the hospitalized. It’s reported that 13 of these women were between 18 and 49, and two were over 50. There have been no reports of men developing the disorder outside the Johnson & Johnson vaccine clinical trials.
Read also: Suspending Fayemi because I visited him is absurd – Fani-Kayode slams APC
Members of the CDC’s Advisory Committee for Immunization Practices argued the benefits of the Johnson & Johnson shot outweighed its risks, however they urged health officials to include a warning label to the vaccine.
Leave a Reply